Multicentre study on prevalence of fractures in transfusion dependent thalassaemic patients

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 773-778

  Ruggiero, L ^a,c   De Sanctis, V ^b  

^a 'Card G Panico' Hospital   (Italy)

^b S ANNA HOSPITAL   (Italy)

^c Ospedale Card G Panico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DEFEROXAMINE; FERRITIN; HEMOGLOBIN;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; BONE MINERALIZATION; CHELATION THERAPY; CHILD; CONFERENCE PAPER; ENDOCRINE DISEASE; FEMALE; FRACTURE; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; PREVALENCE; RECURRENT DISEASE; THALASSEMIA;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BETA-THALASSEMIA; BLOOD TRANSFUSION; BONE AND BONES; CHILD; CHILD, PRESCHOOL; FEMALE; FERRITINS; FRACTURES, BONE; HEMOGLOBINS; HUMANS; INFANT; ITALY; MALE; RISK FACTORS;

EID: 0032429343     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Dines DM, Canale VC, Arnold WD. Fractures in thalassemia. J Bone Joint Surg 1976; 58: 662-666.
2. Exarchou E, Politou C, Vretou E, Pasparakis D, Madessis G, Caramerou A. Fractures and epiphyseal deformities in beta-thalassemia. Clin Orthop 1984; 189: 229-233.
3. Giardina PJ, Schneider R, Lesser M, Simmons B, Rodriguez A. Gertner J, New M, Hilgartner MW. Abnormal bone metabolism in thalassemia. In: Ando S. Brancati C, eds. Endocrine Disorders in Thalassemia. Berlin-Heidelberg-New York: Springer-Verlag, 1995; 39-46.
4. Michelson J, Cohen A. Incidence and treatment of fractures in thalassemia. J Orthop Trauma 1988; 2: 29-32.
5. Alaiyan H, Mittelmeier H, Graf N. Skeletal changes in thalassemia. Z Orthop 1988; 126: 437-447.
6. Giuzio E, Bria M, Bisconte MG, Caracciolo M, Misasi M, Nastro M, Brancati C. Skeletal changes in thalassemia major. ltal J Orthop Traumatol 1991; 17: 269-275.
7. Gratwick GM, Bullough PG, Bohne WH, Markenson AL, Peterson CM. Thalassemic osteoartropathy. Ann Intern Med 1978; 88: 494-501.
8. Johanson NA. Muscoloskeletal problems in hemoglobinopathy. Orthop Clin North Am 1990; 21: 191-198.
9. Bagni B, De Sanctis V, Bagni I, Cavallini AR, Bonaccorsi G, Vullo C. Osteopenia in thalassemic patients with primary and secondary amenorrhoea. In: Ando S, Brancati C, eds. Endocrine Disorders in Thalassemia. Berlin-Heidelberg-New York: Springer-Verlag, 1995; 53-57.
10. De Sanctis V and Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995; 42: 581-586.
11. Orvieto R, Leichter I, Rachmilewitz EA, Margulies JY. Bone density, mineral content and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions and treatment with desferrioxamine. Calcif Tissue Int 1992; 50: 397-399.
12. Katz K, Horev G, Goshen J, Tamary H. The pattern of bone disease in transfusion-dependent thalassemia major patients. Isr J Med Sci 1994; 30: 577-580.